1
|
Makaryan V, Rosenthal EA, Bolyard AA, Kelley ML, Below JE, Bamshad MJ, Bofferding KM, Smith JD, Buckingham K, Boxer LA, Skokowa J, Welte K, Nickerson DA, Jarvik GP, Dale DC. TCIRG1-associated congenital neutropenia. Hum Mutat 2014; 35:824-7. [PMID: 24753205 DOI: 10.1002/humu.22563] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2013] [Accepted: 03/28/2014] [Indexed: 11/12/2022]
Abstract
Severe congenital neutropenia (SCN) is a rare hematopoietic disorder, with estimated incidence of 1 in 200,000 individuals of European descent, many cases of which are inherited in an autosomal dominant pattern. Despite the fact that several causal genes have been identified, the genetic basis for >30% of cases remains unknown. We report a five-generation family segregating a novel single nucleotide variant (SNV) in TCIRG1. There is perfect cosegregation of the SNV with congenital neutropenia in this family; all 11 affected, but none of the unaffected, individuals carry this novel SNV. Western blot analysis show reduced levels of TCIRG1 protein in affected individuals, compared to healthy controls. Two unrelated patients with SCN, identified by independent investigators, are heterozygous for different, rare, highly conserved, coding variants in TCIRG1.
Collapse
Affiliation(s)
- Vahagn Makaryan
- Department of Medicine, Divisions of GIM, University of Washington, Seattle, Washington
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Bigham AW, Buckingham KJ, Husain S, Emond MJ, Bofferding KM, Gildersleeve H, Rutherford A, Astakhova NM, Perelygin AA, Busch MP, Murray KO, Sejvar JJ, Green S, Kriesel J, Brinton MA, Bamshad M. Host genetic risk factors for West Nile virus infection and disease progression. PLoS One 2011; 6:e24745. [PMID: 21935451 PMCID: PMC3174177 DOI: 10.1371/journal.pone.0024745] [Citation(s) in RCA: 86] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2011] [Accepted: 08/16/2011] [Indexed: 11/19/2022] Open
Abstract
West Nile virus (WNV), a category B pathogen endemic in parts of Africa, Asia and Europe, emerged in North America in 1999, and spread rapidly across the continental U.S. Outcomes of infection with WNV range from asymptomatic to severe neuroinvasive disease manifested as encephalitis, paralysis, and/or death. Neuroinvasive WNV disease occurs in less than one percent of cases, and although host genetic factors are thought to influence risk for symptomatic disease, the identity of these factors remains largely unknown. We tested 360 common haplotype tagging and/or functional SNPs in 86 genes that encode key regulators of immune function in 753 individuals infected with WNV including: 422 symptomatic WNV cases and 331 cases with asymptomatic infections. After applying a Bonferroni correction for multiple tests and controlling for population stratification, SNPs in IRF3 (OR 0.54, p = 0.035) and MX1, (OR 0.19, p = 0.014) were associated with symptomatic WNV infection and a single SNP in OAS1 (OR 9.79, p = 0.003) was associated with increased risk for West Nile encephalitis and paralysis (WNE/P). Together, these results suggest that genetic variation in the interferon response pathway is associated with both risk for symptomatic WNV infection and WNV disease progression.
Collapse
Affiliation(s)
- Abigail W. Bigham
- Department of Pediatrics, University of Washington, Seattle, Washington, United States of America
- * E-mail: (AWB); (MB)
| | - Kati J. Buckingham
- Department of Pediatrics, University of Washington, Seattle, Washington, United States of America
| | - Sofia Husain
- Department of Pediatrics, University of Washington, Seattle, Washington, United States of America
| | - Mary J. Emond
- Department of Biostatistics, University of Washington, Seattle, Washington, United States of America
| | - Kathryn M. Bofferding
- Department of Pediatrics, University of Washington, Seattle, Washington, United States of America
| | - Heidi Gildersleeve
- Department of Pediatrics, University of Washington, Seattle, Washington, United States of America
| | - Ann Rutherford
- Department of Internal Medicine, Division of Infectious Diseases, University of Utah, Salt Lake City, Utah, United States of America
| | - Natalia M. Astakhova
- Department of Biology, Georgia State University, Atlanta, Georgia, United States of America
| | - Andrey A. Perelygin
- Department of Biology, Georgia State University, Atlanta, Georgia, United States of America
| | - Michael P. Busch
- Blood Systems, San Francisco, California, United States of America
| | - Kristy O. Murray
- School of Public Health, University of Texas Health Sciences Center at Houston, Houston, Texas, United States of America
| | - James J. Sejvar
- National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America
| | - Sharone Green
- Department of Medicine, Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
| | - John Kriesel
- Department of Internal Medicine, Division of Infectious Diseases, University of Utah, Salt Lake City, Utah, United States of America
| | - Margo A. Brinton
- Department of Biology, Georgia State University, Atlanta, Georgia, United States of America
| | - Michael Bamshad
- Department of Pediatrics, University of Washington, Seattle, Washington, United States of America
- * E-mail: (AWB); (MB)
| |
Collapse
|